– Reuters
Keybanc Maintains Overweight on Azenta, Lowers Price Target to $70
Keybanc analyst Paul Knight maintains Azenta (NASDAQ:AZTA) with a Overweight and lowers the price target from $90 to $70.
Related Posts
Dawson Geophysical Q2 EPS $(0.38) Down From $0.06 YoY
Dawson Geophysical (NASDAQ:DWSN) reported quarterly losses of $(0.38) per share. This is a 733.33 percent decrease over earnings of $0.06 per share from the same period last year.
Analyst Sees Attractive Entry Opportunity After BioCryst’s Pipeline Setback
Tucked in its Q4 earnings press release, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a setback on the early-stage BCX10013 study. The company…
Clarus: Return On Capital Employed Insights
Looking at Q1, Clarus (NASDAQ:CLAR) earned $5.69 million, a 2.99% increase from the preceding quarter. Clarus's sales decreased to $75.33 million, a 0.81% change since Q4. In Q4, Clarus earned $5.52 million, whereas sales reached $75.95 million.